Category: Federal Forum Posters
Purpose: Osteoporosis is often an under-diagnosed disease due to the lack signs and symptoms until a fracture actually occurs, and the lack of evidence for screening. Multiple tools are available; however, they do not always accurately predict bone disease. Patients in the home based primary care population often have multiple comorbidities, and are at high-risk for osteoporosis. In addition, many of these patients are home-bound, and have difficulties obtaining DEXA scans. The purpose of this study is to determine what proportion of patients pharmacists can appropriately screen, and refer for, a DEXA scan.
Methods: This project was submitted to the Institutional Review Board, and has been approved for data collection through November 2018. The analysis will be a retrospective descriptive study utilizing chart review of patients receiving care from Captain James A. Lovell Federal Health Care Center HBPC to determine their need for osteoporosis screening, treatment, and monitoring. Patients will be excluded if they are receiving hospice or palliative care, have a limited life expectancy per HBPC primary care provider, or are having their osteoporosis managed by a VA endocrinologist or rheumatologist, or an outside provider. Patients are included in the study if they are enrolled in the HBPC program during the study period. De-identified data to be collected through chart review include, age, gender, race/ethnicity, weight, height, smoking history, fracture history, Vitamin D levels, and DEXA scans (including dates). From this data set, FRAX and OST scores will be calculated and analyzed. Descriptive statistics will be utilized to evaluate the effectiveness of the screening process.
Results: not applicable
Conclusion: not applicable
Xuxuan Liu– PGY1 Pharmacy Resident, Captain James A. Lovell FHCC, Waukegan, IL